It is definitely a strong contender.

Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over ...

Pfizers approaching patent cliff and expanding pipeline remain central as the pharmaceutical group advances oncology programs ...

The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation ...

U.S. drugmaker Pfizer has temporarily discontinued Premarin vaginal cream in India, shrinking estrogen therapy options for ...

As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...

Pfizer has paused Premarin vaginal cream supply in India due to supply challenges, limiting menopause treatment options and ...

Drug pricing matters, but pipelines matter even more.

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...

By Mrinalika Roy July 16 (Reuters) - U.S. drugmaker Pfizer has temporarily discontinued Premarin vaginal cream in India, ...

PFE's oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates may ...